BiotechTube
Home/VBI Vaccines/Michel De Wilde
MD

Michel De Wilde

Director, Chair of Scientific and Clinical Advisory Boards

VBI Vaccines

Therapeutic Areas

OncologyInfectious Diseases

VBI Vaccines Pipeline

DrugIndicationPhase
VBI-1901Recurrent Glioblastoma (GBM)Phase 2
VBI-2901COVID-19Phase 1
VBI-2905COVID-19 / CoronavirusPhase 1
VBI-1501Cytomegalovirus (CMV)Phase 1

Leadership Team at VBI Vaccines

PV
Pierre Van Damme
Scientific and Clinical Advisory Board Member
AF
Adam Finn
Scientific and Clinical Advisory Board Member
PA
Peter A. Patriarca
Scientific and Clinical Advisory Board Member
DS
Daniel Shouval
Scientific and Clinical Advisory Board Member
JD
John D. Grabenstein
Scientific and Clinical Advisory Board Member
BS
Bruce Smith
Scientific and Clinical Advisory Board Member
DB
Damian Braga
Director, Chair of Commercial Advisory Board
View full VBI Vaccines profile